Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

28,000

Employees28,000

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

28,000

Employees28,000

AMGN Key Statistics

Market cap

147.75B

Market cap147.75B

Price-Earnings ratio

24.27

Price-Earnings ratio24.27

Dividend yield

3.43%

Dividend yield3.43%

Average volume

3.18M

Average volume3.18M

High today

$276.50

High today$276.50

Low today

$258.62

Low today$258.62

Open price

$266.47

Open price$266.47

Volume

4.22M

Volume4.22M

52 Week high

$346.85

52 Week high$346.85

52 Week low

$253.30

52 Week low$253.30

AMGN News

Seeking Alpha 6d

Amgen’s Tepezza becomes first U.K.-medicine approved for adults with thyroid eye disease

The U.K. drug regulator on Wednesday approved Amgen’s (NASDAQ:AMGN) intravenous medication teprotumumab (Tepezza) as the country’s medicine indicated specifical...

Sherwood News 7d

Pharma imports surged this year as drugmakers grapple with tariff threats

Drugmakers said tax cuts are better than tariffs for encouraging domestic manufacturing. They’re moving production to the US anyway. The US imported $20 billio...

Analyst ratings

50%

of 32 ratings

Buy

40.6%

Hold

50%

Sell

9.4%

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.